{"entity":{"type":"insider","cik":"0001550455","url":"/insider/0001550455","json_url":"/insider/0001550455.json","name":"Bender James G.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":4,"first":"2012-05-31","last":"2013-08-30","span_basis":"filed_date"},"name_variants":[{"name":"Bender James G.","source":"filing","n_filings":4,"first_seen":"2012-05-31","last_seen":"2013-08-30"}],"transactions":[{"id":4627150,"accession":"0001181431-13-047124","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-13-047124","line_url":"/filing/0001181431-13-047124#line-6","is_derivative":false,"issuer_cik":"0000822411","issuer_name":"ImmunoCellular Therapeutics, Ltd.","issuer_ticker":"IMUC","issuer_name_source":null,"issuer_url":"/issuer/0000822411","owner_cik":"0001550455","owner_name":"Bender James G.","owner_display_name":"Bender James G.","owner_url":"/insider/0001550455","role":"Officer (VP, Product Development & Mfg)","role_mark":"O","role_mark_label":"Officer (VP, Product Development & Mfg)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Product Development & Mfg.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":2700.0,"total_display":"2,700.00","total_whole":"2,700","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-29","filed_date":"2013-08-30","scope":"insider"},{"id":4627145,"accession":"0001181431-13-047124","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-13-047124","line_url":"/filing/0001181431-13-047124","is_derivative":false,"issuer_cik":"0000822411","issuer_name":"ImmunoCellular Therapeutics, Ltd.","issuer_ticker":"IMUC","issuer_name_source":null,"issuer_url":"/issuer/0000822411","owner_cik":"0001550455","owner_name":"Bender James G.","owner_display_name":"Bender James G.","owner_url":"/insider/0001550455","role":"Officer (VP, Product Development & Mfg)","role_mark":"O","role_mark_label":"Officer (VP, Product Development & Mfg)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Product Development & Mfg.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13303.0,"shares_display":"13,303","price_per_share":2.857517101405698,"price_display":"2.86","price_state":"stated","total_value":38013.55,"total_display":"38,013.55","total_whole":"38,014","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-28","filed_date":"2013-08-30","scope":"insider","n_lines":3},{"id":9252804,"accession":"0001181431-13-011843","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-011843","line_url":"/filing/0001181431-13-011843","is_derivative":false,"issuer_cik":"0001550455","issuer_name":"ImmunoCellular Therapeutics, Ltd.","issuer_ticker":"IMUC","issuer_name_source":null,"issuer_url":"/issuer/0001550455","owner_cik":"0001550455","owner_name":"Bender James G.","owner_display_name":"Bender James G.","owner_url":"/insider/0001550455","role":"Officer (VP, Product Development & Mfg)","role_mark":"O","role_mark_label":"Officer (VP, Product Development & Mfg)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Product Development & Mfg.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":3.5987142857142858,"price_display":"3.60","price_state":"stated","total_value":25191.0,"total_display":"25,191.00","total_whole":"25,191","shares_owned_after":679.0,"shares_owned_after_display":"679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-01","filed_date":"2013-02-22","scope":"insider","n_lines":3},{"id":2353274,"accession":"0001250853-12-000057","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001250853-12-000057","line_url":"/filing/0001250853-12-000057","is_derivative":false,"issuer_cik":"0000822411","issuer_name":"ImmunoCellular Therapeutics, Ltd.","issuer_ticker":"IMUC","issuer_name_source":null,"issuer_url":"/issuer/0000822411","owner_cik":"0001550455","owner_name":"Bender James G.","owner_display_name":"Bender James G.","owner_url":"/insider/0001550455","role":"Officer (VP Product Development & Mfg)","role_mark":"O","role_mark_label":"Officer (VP Product Development & Mfg)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Product Development & Mfg.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":3.5987142857142858,"price_display":"3.60","price_state":"stated","total_value":25191.0,"total_display":"25,191.00","total_whole":"25,191","shares_owned_after":1479.0,"shares_owned_after_display":"1,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-01","filed_date":"2012-06-06","scope":"insider","n_lines":3},{"id":3518988,"accession":"0001250853-12-000056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001250853-12-000056","line_url":"/filing/0001250853-12-000056","is_derivative":false,"issuer_cik":"0000822411","issuer_name":"ImmunoCellular Therapeutics, Ltd.","issuer_ticker":"IMUC","issuer_name_source":null,"issuer_url":"/issuer/0000822411","owner_cik":"0001550455","owner_name":"Bender James G.","owner_display_name":"Bender James G.","owner_url":"/insider/0001550455","role":"Officer (VP, Product Development & Mfg)","role_mark":"O","role_mark_label":"Officer (VP, Product Development & Mfg)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Product Development & Mfg.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":3.9205714285714284,"price_display":"3.92","price_state":"stated","total_value":27444.0,"total_display":"27,444.00","total_whole":"27,444","shares_owned_after":7879.0,"shares_owned_after_display":"7,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-31","filed_date":"2012-05-31","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000822411","name":"ImmunoCellular Therapeutics, Ltd.","url":"/issuer/0000822411","role":"Officer (VP, Product Development & Mfg)","n_filings":4,"first_seen":"2012-05-31","last_seen":"2013-08-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001550455","retrieved_at":"2026-08-22T22:19:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}